211 related articles for article (PubMed ID: 1301849)
41. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
Bonavida B; Katz J; Gottlieb M
J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
[TBL] [Abstract][Full Text] [Related]
42. Effects of ultraviolet irradiation on natural killer cell function in systemic lupus erythematosus.
Nived O; Johansson I; Sturfelt G
Ann Rheum Dis; 1992 Jun; 51(6):726-30. PubMed ID: 1616354
[TBL] [Abstract][Full Text] [Related]
43. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
Tsokos GC; Rook AH; Djeu JY; Balow JE
Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
[TBL] [Abstract][Full Text] [Related]
44. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
Miller ML; Lantner R; Pachman LM
J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
[TBL] [Abstract][Full Text] [Related]
45. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
[TBL] [Abstract][Full Text] [Related]
46. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.
Giacomelli R; Passacantando A; Frieri G; Parzanese I; D'Alò S; Vernia P; Pimpo MT; Petrucci C; Caprilli R; Cifone MG; Tonietti G
Clin Exp Immunol; 1999 Jan; 115(1):72-7. PubMed ID: 9933422
[TBL] [Abstract][Full Text] [Related]
47. Stimulation of NK-like CMC by skin test antigens in vitro is depressed in patients with SLE.
Tartof D; Check IJ; Medof ME
Clin Exp Immunol; 1982 Nov; 50(2):253-8. PubMed ID: 7151326
[TBL] [Abstract][Full Text] [Related]
48. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
Wright SC; Bonavida B
J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus.
Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY
Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017
[TBL] [Abstract][Full Text] [Related]
50. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
Bonavida B; Wright SC
J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
[TBL] [Abstract][Full Text] [Related]
51. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
Goto M; Tanimoto K; Horiuchi Y
Arthritis Rheum; 1980 Nov; 23(11):1274-81. PubMed ID: 6969594
[TBL] [Abstract][Full Text] [Related]
52. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women.
Stopińska-Głuszak U; Waligóra J; Grzela T; Głuszak M; Jóźwiak J; Radomski D; Roszkowski PI; Malejczyk J
J Reprod Immunol; 2006 Feb; 69(1):65-75. PubMed ID: 16236362
[TBL] [Abstract][Full Text] [Related]
53. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
54. Interferon and natural killer cells in systemic lupus erythematosus.
Strannegård O; Hermodsson S; Westberg G
Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
[TBL] [Abstract][Full Text] [Related]
55. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
[TBL] [Abstract][Full Text] [Related]
56. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
57. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
[TBL] [Abstract][Full Text] [Related]
58. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
59. Relationship between radical production and natural killer cytotoxic factor (NKCF) in canine natural killer (NK) cell-mediated cytotoxicity.
Nakada Y; Tsukatani Y; Kosaka T; Kuwabara M; Tanaka S; Fujiwara K
Vet Immunol Immunopathol; 1997 Mar; 55(4):273-82. PubMed ID: 9151399
[TBL] [Abstract][Full Text] [Related]
60. Natural killer augmentation in systemic lupus erythematosus via a soluble mediator derived from human lymphocytes.
Kaufman DB
Arthritis Rheum; 1982 May; 25(5):562-7. PubMed ID: 7082401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
